The dysfunction of BP180/collagen XVII in keratinocytes promotes melanoma progression
Authors:
- 21 August 2019
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 38 (50) , 7491-7503
Abstract
BP180, also termed collagen XVII, is a hemidesmosomal transmembrane glycoprotein expressed in basal keratinocytes, and functions as a cell–matrix adhesion molecule in the dermal–epidermal junction of the skin. Its function, other than cell–matrix adhesion, remains unclear. We generated a mouse strain with BP180 dysfunction (termed ∆NC16A), which develops spontaneous skin inflammation accompanied by an influx of myeloid derived suppressor cells (MDSCs). We used the B16 mouse melanoma model to demonstrate that BP180 dysfunction in either skin or basal keratinocytes promotes MDSC influx into skin and tumor progression. MDSC depletion reduced tumor progression in ∆NC16A mice, demonstrating a critical role for BP180 dysfunction-driven MDSCs in melanoma progression. This study provides the first direct evidence that BP180, a cell–cell matrix adhesion molecule, possesses antitumor function through modulating infiltration of MDSCs. Basal keratinocytes actively participate in skin microenvironment changes caused by BP180 dysfunction. ∆NC16A mice could be a new animal model to study the melanoma microenvironment.Keywords
Funding Information
- U.S. Department of Health & Human Services | National Institutes of Health (R01 AI40768, R01 AI61430)
- UNC | University of North Carolina at Chapel Hill (UNC Cancer Center Research Award, UNC Graduate School Dissertation Completion Fellowship)
This publication has 56 references indexed in Scilit:
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Asymmetric cell divisions promote Notch-dependent epidermal differentiationNature, 2011
- The Inflammasome Component Nlrp3 Impairs Antitumor Vaccine by Enhancing the Accumulation of Tumor-Associated Myeloid-Derived Suppressor CellsCancer Research, 2010
- Metastasis in an orthotopic murine model of melanoma is independent of RAS/RAF mutationMelanoma Research, 2010
- The biology of myeloid‐derived suppressor cells: The blessing and the curse of morphological and functional heterogeneityEuropean Journal of Immunology, 2010
- A Mouse Model of Generalized Non-Herlitz Junctional Epidermolysis BullosaJournal of Investigative Dermatology, 2010
- Inherited epidermolysis bullosaOrphanet Journal of Rare Diseases, 2010
- Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instabilityCarcinogenesis, 2009
- Myeloid-Derived Suppressor Cells: Linking Inflammation and CancerThe Journal of Immunology, 2009
- Experimental models for the autoimmune and inflammatory blistering disease, Bullous pemphigoidArchives of Dermatological Research, 2007